Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-15 | Amended | $26,763,207 | $12,266,681 | Equity Only | 06b | SEC link |
| 2025-02-12 | New | $14,496,526 | $14,496,526 | Equity Only | 06b | SEC link |
| 2023-12-06 | Amended | $24,689,802 | $9,177,233 | Equity Only | 06b | SEC link |
| 2022-10-04 | New | $15,512,569 | $15,512,569 | Equity Only | 06b | SEC link |
| 2021-07-23 | New | $9,000,000 | Unknown | Equity and Debt | SEC link |
| Name | Role |
|---|---|
| Balkrishan Gill | Director |
| Alexandra Glucksmann | Director |
| Jacob Hooker | Director, Executive |
| Ryan Katz | Director |
| Kevin Lalande | Director |
| Jerrold Rosenbaum | Director |
| Richard Simon | Director |
| David Southwell | Director |
| Pranav Tadi | Executive |